banner
laurenmerzmd.bsky.social
@laurenmerzmd.bsky.social
Heme fellow at Dana-Farber/MGH/BWH🩸| Women’s Health and Health Equity research focused 🙎‍♀️| Ask me about the Duffy null phenotype 🧬 | Proud University of Michigan alum 〽️ | dog mom 🐕 #Hemesky #Medsky
Reposted
Join @laurenmerzmd.bsky.social at 5 PM PST on @ash-hematology.bsky.social’s virtual platform during the #ASH24 poster walk highlighting her work, Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer.
December 11, 2024 at 5:14 PM
Come talk with me today at 1:15 about universal Duffy testing and how we optimally use the new Duffy null specific ANC reference intervals! #ASH24
December 7, 2024 at 5:59 PM
Reposted
If we ignore Duffy-null associated neutrophil counts (DANC), we contribute to major disparities in oncology care and clinical trial enrollment. Whether you’re a clinical trialist or clinician, a must-read from @laurenmerzmd.bsky.social and coauthors #medsky #hemesky 🩸🧪

www.nejm.org/doi/abs/10.1...
The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM
Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of African or Arab ancestry.
www.nejm.org
November 25, 2024 at 9:34 PM
Many absolute neutrophil count thresholds in cancer care do not account for normal levels in people with the Duffy null phenotype— the majority of whom are Black or Middle Eastern.

👇Check out some strategies we propose to address systemic racism in cancer care!

www.nejm.org/doi/full/10....
The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM
Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of African or Arab ancestry.
www.nejm.org
November 23, 2024 at 4:45 PM